166 related articles for article (PubMed ID: 22023477)
1. Novel strategies to improve DNA vaccine immunogenicity.
Coban C; Kobiyama K; Aoshi T; Takeshita F; Horii T; Akira S; Ishii KJ
Curr Gene Ther; 2011 Dec; 11(6):479-84. PubMed ID: 22023477
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular mechanisms of DNA vaccines.
Coban C; Koyama S; Takeshita F; Akira S; Ishii KJ
Hum Vaccin; 2008; 4(6):453-6. PubMed ID: 18535407
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines: a simple DNA sensing matter?
Coban C; Kobiyama K; Jounai N; Tozuka M; Ishii KJ
Hum Vaccin Immunother; 2013 Oct; 9(10):2216-21. PubMed ID: 23912600
[TBL] [Abstract][Full Text] [Related]
4. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.
Ishii KJ; Kawagoe T; Koyama S; Matsui K; Kumar H; Kawai T; Uematsu S; Takeuchi O; Takeshita F; Coban C; Akira S
Nature; 2008 Feb; 451(7179):725-9. PubMed ID: 18256672
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
6. Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination.
Kobiyama K; Jounai N; Aoshi T; Tozuka M; Takeshita F; Coban C; Ishii KJ
Vaccines (Basel); 2013 Jul; 1(3):278-92. PubMed ID: 26344113
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267
[TBL] [Abstract][Full Text] [Related]
8. Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines.
Qiao C; Liu J; Yang J; Li Y; Weng J; Shao Y; Zhang X
Biomaterials; 2016 Apr; 85():1-17. PubMed ID: 26851653
[TBL] [Abstract][Full Text] [Related]
9. Modulating APOBEC expression enhances DNA vaccine immunogenicity.
Almeida RR; Raposo RA; Coirada FC; da Silva JR; de Souza Ferreira LC; Kalil J; Nixon DF; Cunha-Neto E
Immunol Cell Biol; 2015 Nov; 93(10):868-76. PubMed ID: 25953029
[TBL] [Abstract][Full Text] [Related]
10. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccines for the prevention and treatment of allergy.
Chua KY; Kuo IC; Huang CH
Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):50-4. PubMed ID: 19532092
[TBL] [Abstract][Full Text] [Related]
12. Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants.
Yu YZ; Li N; Ma Y; Wang S; Yu WY; Sun ZW
Eur J Immunol; 2013 Jan; 43(1):228-39. PubMed ID: 23037552
[TBL] [Abstract][Full Text] [Related]
13. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.
Rahimi MT; Sarvi S; Sharif M; Abediankenari S; Ahmadpour E; Valadan R; Ramandie MF; Hosseini SA; Daryani A
Parasitol Res; 2017 Feb; 116(2):609-616. PubMed ID: 27909791
[TBL] [Abstract][Full Text] [Related]
14. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
[TBL] [Abstract][Full Text] [Related]
15. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
16. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
17. The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination.
Ni J; Schirrmacher V; Fournier P
Vaccine; 2010 Oct; 28(42):6891-900. PubMed ID: 20709006
[TBL] [Abstract][Full Text] [Related]
18. Augmenting the immunogenicity of DNA vaccines: role of plasmid-encoded Flt-3 ligand, as a molecular adjuvant in genetic vaccination.
Nayak BP; Sailaja G; Jabbar AM
Virology; 2006 May; 348(2):277-88. PubMed ID: 16563456
[TBL] [Abstract][Full Text] [Related]
19. A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.
Gupta S; Termini JM; Rivas Y; Otero M; Raffa FN; Bhat V; Farooq A; Stone GW
Vaccine; 2015 Sep; 33(38):4798-806. PubMed ID: 26241951
[TBL] [Abstract][Full Text] [Related]
20. Control of Heterologous Simian Immunodeficiency Virus SIV
Singh S; RamÃrez-Salazar EG; Doueiri R; Valentin A; Rosati M; Hu X; Keele BF; Shen X; Tomaras GD; Ferrari G; LaBranche C; Montefiori DC; Das J; Alter G; Trinh HV; Hamlin C; Rao M; Dayton F; Bear J; Chowdhury B; Alicea C; Lifson JD; Broderick KE; Sardesai NY; Sivananthan SJ; Fox CB; Reed SG; Venzon DJ; Hirsch VM; Pavlakis GN; Felber BK
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
